DEVELOPMENT OF CANDIDATE ROTAVIRUS VACCINES

被引：63
作者：
BISHOP, RF
机构：
[1] Department of Gastroenterology, Royal Children's Hospital, Melbourne
来源：
VACCINE | 1993年 / 11卷 / 02期
关键词：
ROTAVIRUSES; EPIDEMIOLOGY; PROTEINS; VACCINE STRATEGIES;
D O I：
10.1016/0264-410X(93)90025-S
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Candidate rotavirus vaccines tested to date have been developed using a 'Jennerian' approach. Strains of bovine and simian rotaviruses that are naturally attenuated for humans have been assessed and found to confer immunity that is serotype specific in a varying proportion of recipients. The spectrum of protection has been widened by developing reassortants in which the bovine or simian gene coding for VP7 (the major outer capsid protein) has been replaced by the corresponding gene from human VP7 types 1, 2, 3 or 4. Once the protective antigen(s) are identified it may be possible to develop subunit vaccines that eliminate side effects sometimes observed with live vaccine candidates.
引用
收藏
页码：247 / 254
页数：8
相关论文
共 63 条
[1]   VACCINIA ROTAVIRUS-VP7 RECOMBINANTS PROTECT MICE AGAINST ROTAVIRUS-INDUCED DIARRHEA [J].
ANDREW, ME ;
BOYLE, DB ;
COUPAR, BEH ;
REDDY, D ;
BELLAMY, AR ;
BOTH, GW .
VACCINE, 1992, 10 (03) :185-191
[2]   VACCINIA VIRUS RECOMBINANTS EXPRESSING THE SA11-ROTAVIRUS VP7-GLYCOPROTEIN GENE INDUCE SEROTYPE-SPECIFIC NEUTRALIZING ANTIBODIES [J].
ANDREW, ME ;
BOYLE, DB ;
COUPAR, BEH ;
WHITFELD, PL ;
BOTH, GW ;
BELLAMY, AR .
JOURNAL OF VIROLOGY, 1987, 61 (04) :1054-1060
[3]   THE IMMUNOGENICITY OF VP7, A ROTAVIRUS ANTIGEN RESIDENT IN THE ENDOPLASMIC-RETICULUM, IS ENHANCED BY CELL-SURFACE EXPRESSION [J].
ANDREW, ME ;
BOYLE, DB ;
WHITFELD, PL ;
LOCKETT, LJ ;
ANTHONY, ID ;
BELLAMY, AR ;
BOTH, GW .
JOURNAL OF VIROLOGY, 1990, 64 (10) :4776-4783
[4]   SYNTHESIS IN ESCHERICHIA-COLI AND IMMUNOLOGICAL CHARACTERIZATION OF A POLYPEPTIDE CONTAINING THE CLEAVAGE SITES ASSOCIATED WITH TRYPSIN ENHANCEMENT OF ROTAVIRUS SA11 INFECTIVITY [J].
ARIAS, CF ;
LIZANO, M ;
LOPEZ, S .
JOURNAL OF GENERAL VIROLOGY, 1987, 68 :633-642
[5]   PRIMING FOR ROTAVIRUS NEUTRALIZING ANTIBODIES BY A VP4 PROTEIN-DERIVED SYNTHETIC PEPTIDE [J].
ARIAS, CF ;
GARCIA, G ;
LOPEZ, S .
JOURNAL OF VIROLOGY, 1989, 63 (12) :5393-5398
[6]  
Bellamy A R, 1990, Adv Virus Res, V38, P1, DOI 10.1016/S0065-3527(08)60858-1
[7]   EVALUATION OF WC3 ROTAVIRUS VACCINE AND CORRELATES OF PROTECTION IN HEALTHY INFANTS [J].
BERNSTEIN, DI ;
SMITH, VE ;
SANDER, DS ;
PAX, KA ;
SCHIFF, GM ;
WARD, RL .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (05) :1055-1062
[8]   PROTECTION FROM ROTAVIRUS REINFECTION - 2-YEAR PROSPECTIVE-STUDY [J].
BERNSTEIN, DI ;
SANDER, DS ;
SMITH, VE ;
SCHIFF, GM ;
WARD, RL .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (02) :277-283
[9]  
BISHOP R, 1990, MED VIROL, V9, P85
[10]   CLINICAL IMMUNITY AFTER NEONATAL ROTAVIRUS INFECTION - A PROSPECTIVE LONGITUDINAL-STUDY IN YOUNG-CHILDREN [J].
BISHOP, RF ;
BARNES, GL ;
CIPRIANI, E ;
LUND, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (02) :72-76
1234567